| ²é¿´: 820 | »Ø¸´: 12 | |||
| ¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û10´Î£¬×÷Õßyork6999Ôö¼Ó½ð±Ò 8 ¸ö | |||
york6999ľ³æÖ®Íõ (ÖªÃû×÷¼Ò)
|
[×ÊÔ´]
Pharmacological Mechanisms in Alzheimer's Therapeutics
|
||
|
Pharmacological Mechanisms in Alzheimer's Therapeutics by Claudio Cuello Springer Oct. 31, 2007 ISBN: 0387978798 Contents xi FOREWORDS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . v William H. Thies Theodore L. Sourkes PREFACE FROM THE EDITOR. . . . . . . . . . . . . . . . . . . . . . . . . . . . . ix A. Claudio Cuello LIST OF CONTRIBUTORS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xv 1. OVERVIEW OF THE ALZHEIMER¡¯S DISEASE PATHOLOGY AND POTENTIAL THERAPEUTIC TARGETS . . . . . . . . . . . . . 1 A. Claudio Cuello 2. TRIAL DESIGNS AND OUTCOMES TO MONITOR NOVEL THERAPEUTICS IN ALZHEIMER¡¯S DISEASE . . . . . . . . . . . . 28 Serge Gauthier 3. THE PHARMACOLOGICAL TREATMENT OF ALZHEIMER¡¯S DISEASE WITH CHOLINESTERASE INHIBITORS AND MEMANTINE . . . . . . . . . . . . . . . . . . 36 Gordon Keith Wilcock 4. M1 MUSCARINIC AGONISTS: A COMPREHENSIVE THERAPY AGAINST MAJOR HALLMARKS OF ALZHEIMER¡¯S DISEASE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50 Abraham Fisher 5. CHOLINERGIC NEURODEGENERATION IN ALZHEIMER¡¯S DISEASE: BASIS FOR NERVE GROWTH FACTOR THERAPY. . . . . Ahmad Salehi, Alexander Kleshevnikov, and William C. Mobley 6. THE RATIONALE FOR GLUTAMATERGIC THERAPY IN ALZHEIMER¡¯S DISEASE. . . . . . . . . . . . . . . . . . . . . . . . . . . 105 Paul T. Francis 7. SECRETASES AS PHARMACOLOGICAL TARGETS IN ALZHEIMER¡¯S DISEASE. . . . . . . . . . . . . . . . . . . . . . . . . . . 113 Nigel M. Hooper and Emma R. L. C. Vardy 8. g-SECRETASE AS A TARGET FOR ALZHEIMER¡¯S DISEASE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125 Michael S. Wolfe 9. THE RATIONALE FOR AN IMMUNOLOGICAL APPROACH TO ALZHEIMER¡¯S THERAPEUTICS . . . . . . . . 141 Dave Morgan 10. NEUROINFLAMMATION, ALZHEIMER DISEASE, AND OTHER AGING DISORDERS . . . . . . . . . . . . . . . . . . . . . 149 Edith G. McGeer and Patrick L. McGeer 11. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs) AND DERIVED Ab42-LOWERING MOLECULES FOR TREATMENT AND PREVENTION OF ALZHEIMER¡¯S DISEASE (AD) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 167 Sascha Weggen, Eva Czirr, Stefanie Leuchtenberger, and Jason Eriksen 12. THE POTENTIAL APPLICATION OF ANTIOXIDANT AGENTS IN ALZHEIMER DISEASE THERAPEUTICS. . . . . 194 Paula I. Moreira, Mark A. Smith, Xiongwei Zhu, Akihiko Nunomura, and George Perry 13. APOLIPOPROTEIN E: A POTENT GENE-BASED THERAPEUTIC TARGET FOR THE TREATMENT OF SPORADIC ALZHEIMER¡¯S DISEASE. . . . . . . . . . . . . . . . 212 Judes Poirier 14. TAU PATHOLOGY AS A TARGET IN ALZHEIMER¡¯S THERAPEUTICS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 223 Khalid Iqbal and Inge Grundke-Iqbal 15. DESIGN OF INHIBITORS OF AMYLOID-b MISFOLDING AND AGGREGATION FOR ALZHEIMER¡¯S THERAPY . . . . 238 Lisbell D. Estrada, Cristian Lasagna, and Claudio Soto 16. POTENTIAL APPLICATIONS OF GLYCOSAMINOGLYCANRELATED COMPOUNDS IN ALZHEIMER¡¯S DISEASE . . . . 255 C¨¦line Morissette, Diane Lacombe, Xianqi Kong, Ahmed Aman, Pascale Krzywkowski, Lioudmila Rodionova, Mounia Azzi, Daniel Delorme, and Barry D. Greenberg 17. MULTIFUNCTIONAL NEUROPROTECTIVE DRUGS FOR THE TREATMENT OF ALZHEIMER¡¯S DISEASE. . . . . 274 Cornelis J. Van der Schyf, Werner J. Geldenhuys, and Moussa B. H. Youdim 18. INTERPRETING CLINICAL STUDIES OF PUTATIVE THERAPEUTICS FOR ALZHEIMER¡¯S DISEASE: THE CASE OF STATINS AND NSAIDs . . . . . . . . . . . . . . . . . . 296 Benjamin Wolozin INDEX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 309 |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : Pharmacological_Mechanisms_in_Alzheimers_Therapeutics.pdf
2016-05-08 14:17:39, 3.05 M
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
ҩѧרҵ¿Î8475 |
» ²ÂÄãϲ»¶
±¾¿ÆÖ£ÖÝ´óѧ£¬Ò»Ö¾Ô¸»ª¶«Ê¦·¶´óѧ282Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
²ÄÁϹ¤³ÌרҵÈÕÓïÉúÇóµ÷¼Á
ÒѾÓÐ5È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ4È˻ظ´
Çóµ÷¼Á£¬Ò»Ö¾Ô¸ÏÃÃÅ´óѧ£¬ÉúÎïÓëÒ½Ò©£¬×Ü·Ö272£¬±¾¿Æ211
ÒѾÓÐ7È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ14È˻ظ´
ÉúÎïÓëÒ½Ò©273Çóµ÷¼Á
ÒѾÓÐ13È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ8È˻ظ´
290Çóµ÷¼Á085701
ÒѾÓÐ13È˻ظ´
ÉúÎïÒ½Ò©µ÷¼Á£üSCIÖпÆÔºÈýÇøÒ»×÷+¶àÏî¿ÆÑгɹû
ÒѾÓÐ5È˻ظ´
22408 318·ÖÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
Pharmaceutical Sciences Encyclopedia-·Ç×ÊÔ´Ìû
ÒѾÓÐ7È˻ظ´
roundsquare
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 5390.2
- Ìû×Ó: 1002
- ÔÚÏß: 111.8Сʱ
- ³æºÅ: 457631
7Â¥2016-05-11 09:26:11
12Â¥2016-10-23 18:32:21
¼òµ¥»Ø¸´
haofeng08042Â¥
2016-05-08 18:57
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
kinggbp3Â¥
2016-05-09 06:13
»Ø¸´
¶¥Ò»Ï£¬Ð»Ð»·ÖÏí ·¢×ÔСľ³æAndroid¿Í»§¶Ë
1000805114Â¥
2016-05-09 09:51
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
2016-05-09 22:14
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
work0376Â¥
2016-05-10 09:59
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
chemosky8Â¥
2016-05-11 15:00
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
hudaiqiang9Â¥
2016-05-11 15:03
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
dahuamao2910Â¥
2016-05-22 17:49
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
yaoxuexuezi11Â¥
2016-10-20 22:58
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
wslld13Â¥
2017-03-16 22:21
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡














»Ø¸´´ËÂ¥